Charlotte's Web Holdings, Inc.·Healthcare

Charlotte's Web Holdings, Inc. (CWEB:CA) Q4 2025 Earnings Call Transcript

Anticipated CMMI Medicare Pilot Program Participation, Regulatory Momentum, and Cost Structure Improvements Position Company for Growth and Pathway to Profitability LOUISVILLE, Colo., March 31, 2026 /PRNewswire/ - (TSX: CWEB) (OTC: CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), a botanical wellness innovation company and the market leader in cannabidiol (CBD) hemp extract wellness products, today announced results for the quarter and year ended December 31, 2025.

Transaction Addresses Capital Structure and Supports Near-Term Operating Priorities, Including Anticipated CMMI Medicare Pilot Program Participation LOUISVILLE, Colo., March 30, 2026 /PRNewswire/ - (TSX: CWEB) (OTCQB: CWBHF) Charlotte's Web Holdings, Inc., a botanical wellness innovation company and the market leader in cannabidiol ("CBD") hemp extract wellness products, today announced a transaction with BT DE Investments, Inc. ("BAT"), a subsidiary of British American Tobacco plc (LSE: BATS and NYSE: BTI), comprising two components: (i) amendment and conversion of BAT's outstanding C$75.3 million principal amount (approximately US$54 million) of the convertible debenture, as well as all accrued interest, into common shares of Charlotte's Web at a conversion price of C$0.94 (approximately US$0.67 at the Bank of Canada exchange rate on March 27, 2026 for estimation purposes); and (ii) a concurrent additional equity investment by BAT of US$10 million by way of a private placement at a price (the "Subscription Price") equal to the greater of (a) C$0.94, or (b) a dollar amount equal to the maximum discount available pursuant to section 607 of the TSX Company Manual applied to the 5-day volume weighted average price of the Company's common shares on the TSX prior to the closing date (collectively, the "Transaction").

LOUISVILLE, Colo., March 24, 2026 /PRNewswire/ - (TSX: CWEB) (OTC: CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company") a botanical wellness innovation company and the market leader in cannabidiol (CBD) hemp extract wellness products, will report its 2025 fourth quarter and full year financial results before market open on March 31, 2026.

LOUISVILLE, Colo., March 20, 2026 /PRNewswire/ - (TSX: CWEB) (OTCQB: CWBHF) Charlotte's Web Holdings, Inc. (the "Company" or "Charlotte's Web"), a botanical wellness innovation company and the market leader in cannabidiol ("CBD") hemp extract wellness products, extends its sincere appreciation to the Centers for Medicare & Medicaid Services (CMS) and the Administration for their leadership in advancing structured access to eligible full‑spectrum hemp products through current CMS Innovation Center models, as reflected in CMS's new Substance Access Beneficiary Engagement Incentive (BEI) guidance pages.

Shares of Charlotte's Web Holdings, Inc. (OTCMKTS:CWBHF - Get Free Report) were up 3.4% during mid-day trading on Thursday. The stock traded as high as $0.9379 and last traded at $0.92. Approximately 884,997 shares were traded during trading, a decline of 0% from the average daily volume of 885,233 shares. The stock had previously
Charlotte's Web Holdings, Inc. engages in farming, manufacturing, marketing, and selling hemp-derived cannabidiol (CBD) wellness products. The company's products categories include hemp extract oil tinctures, such as liquid products; gummies comprising sleep, stress, immunity, and exercise recovery products; and capsules, CBD topical creams, and lotions, as well as products for pets under the Charlotte's Web, CBD Medic, CBD Clinic, and Harmony Hemp brands. Its products contain naturally occurring phytocannabinoids, including CBD, cannabichromene, cannabigerol, cannabinol, terpenes, flavonoids, and other beneficial hemp compounds. The company distributes its products through retail outlets and health care practitioners, as well as online through its website. It has a collaboration between its CW Labs science division and the University at Buffalo's Center for Integrated Global Biomedical Sciences to advance hemp cannabinoid science through a research program; and scientific collaboration with McLean Hospital. The company was formerly known as Stanley Brothers Holdings Inc. and changed its name to Charlotte's Web Holdings, Inc. in July 2018. Charlotte's Web Holdings, Inc. was founded in 2013 and is headquartered in Denver, Colorado.
Healthcare
Drug Manufacturers - Specialty & Generic
112
2018-09-12
2.33